Striatal Interneurons In Corticobasal Degeneration is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The striatum, comprising the caudate nucleus and putamen, is affected in Corticobasal Degeneration (CBD) with involvement of both projection neurons and interneurons. Striatal interneurons play crucial roles in modulating basal ganglia output and their dysfunction contributes to the movement disorder phenotype of CBD.
¶ Location and Structure
- Caudate nucleus: Head, body, and tail
- Putamen: External segment of the lenticular nucleus
- Striosome/matrix compartments: Functional subdivisions
- Neurovascular supply: Middle cerebral artery branches
- D1-expressing: Direct pathway (Go)
- D2-expressing: Indirect pathway (NoGo)
- GABAergic output: To GPi and SNr
- Cholinergic interneurons: Large aspiny neurons
- Parvalbumin (PV) interneurons: Fast-spiking
- Somatostatin (SST) interneurons: NPY-expressing
- TH interneurons: Tyrosine hydroxylase-expressing
- Cholinergic neurons: Variable involvement
- PV interneurons: May show relative preservation
- SST interneurons: Pathological changes
- TH interneurons: Possible vulnerability
- 4R-tau inclusions: In both projection neurons and interneurons
- Coiled bodies: Oligodendroglial pathology
- Astrocytic plaques: Characteristic astrocyte pathology
- Neuronal loss: Variable severity
- D1 MSNs: GABAergic output to GPi/SNr
- Effect: Movement facilitation
- Dysfunction: Impaired in CBD
- D2 MSNs: Output to GPe
- STN excitation: Via GPe
- Dysfunction: Contributes to rigidity
- Cholinergic tone: Altered in CBD
- PV inhibition: Pathological microcircuit changes
- SST modulation: Neuropeptide changes
- Bradykinesia: Impaired movement initiation
- Rigidity: Enhanced tone
- Dystonia: Abnormal postures
- Myoclonus: Cortical origin
- Executive dysfunction: Frontal lobe involvement
- Memory deficits: Working memory impairment
- Behavioral changes: Apathy, disinhibition
- Aggregation: 4R-tau filament formation
- Hyperphosphorylation: Abnormal post-translational modification
- Spread: Within corticostriatal circuits
- Synaptic pathology: Pre-synaptic terminals
- Dopamine: Altered striatal dopamine
- Acetylcholine: Cholinergic interneuron changes
- GABA: Inhibitory signaling modifications
- Glutamate: Excitatory/inhibitory balance
- Microglial activation: Chronic inflammation
- Cytokine release: TNF-α, IL-1β, IL-6
- Complement activation: Immune-mediated processes
- Levodopa: Variable response
- Dopamine agonists: May provide some benefit
- Limitations: Less effective than in PD
- Cholinergic modulation: Anticholinergic agents
- GABAergic drugs: For myoclonus
- Future approaches: Cell-type specific targets
- Tau aggregation inhibitors: 4R-tau targeting
- Immunotherapy: Anti-tau approaches
- Neuroprotection: Neurotrophic factors
The study of Striatal Interneurons In Corticobasal Degeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496-503. PMID: 23359374.
-
Kouri N, Whitwell JL, Josephs KA, Rademakers R, Dickson DW. Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol. 2011;7(5):263-272. PMID: 21458321.
-
Lee SE, Rabinovici GD, Mayo MC, et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 2011;70(2):327-340. PMID: 21823156.
-
Graybiel AM. The basal ganglia. Curr Biol. 2000;10(14):R509-R511. PMID: 10912072.
-
Steiner H, Tseng KY. Handbook of Basal Ganglia Structure and Function. Academic Press; 2017.
-
Gertler TS, Chan CS, Surmeier DJ. Dichotomous anatomical properties of adult striatal medium spiny neurons. J Neurosci. 2008;28(44):10814-10824. PMID: 18945886.
-
Zhou FW, Jin Y, Matta SG, Xu M, Zhou FM. An ultra-short dopamine pathway facilitates behavioral exploration. Mol Psychiatry. 2017;22(11):1504-1515. PMID: 28322258.
-
Calabresi P, Picconi B, Tozzi A, Ghiglieri V, Di Filippo M. Direct and indirect pathways of basal ganglia: a critical reappraisal. Nat Neurosci. 2014;17(8):1022-1030. PMID: 25059479.